Latham & Watkins Advises Syzygy Plasmonics in its US$23 Million Series B Financing

A Boston-based emerging companies team advises the technology company in its financing.

April 06, 2021

Syzygy Plasmonics, a technology company developing the world’s highest performance photocatalyst for the industrial gas, chemical, and energy industries, has announced a US$23 million Series B financing led by Horizons Ventures with participation from new global investors including Equinor Ventures. Previous Seed and Series A investors including The Engine, GOOSE Capital, and Evok Innovations also participated in the financing round. The capital raised will fund product development, hiring and the commercialization of Syzygy’s photocatalytic reactor, which are key steps toward delivering on the company’s mission to reduce emissions using light to replace heat from fossil fuels in chemical manufacturing and production.

Latham & Watkins LLP represented Syzygy Plasmonics in the financing with a Boston-based emerging companies team led by partner Spencer Ricks and associate Tyler Mills.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.